Kolexia
Subic Levrero Miroslava
Gastro-entérologie
Hôpital La Croix-Rousse
Lyon, France
33 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hépatite Hépatite B Tumeurs du foie Hépatite B chronique Cirrhose du foie Carcinome hépatocellulaire Hépatite chronique Hépatite C Fibrose

Industries

B3TSI
16 collaboration(s)
Dernière en 2023
Abbvie
13 collaboration(s)
Dernière en 2023
Gilead
11 collaboration(s)
Dernière en 2023
Mayoly Spindler
2 collaboration(s)
Dernière en 2023

Dernières activités

Circulating microRNAs improve bacterial infection diagnosis and overall survival prediction in acute decompensation of liver cirrhosis.
iScience   20 juillet 2023
Traitement par bulevirtide des patients co-infectés par le VIH-VHB-VHD. Analyse des données en vie réelle.
Journées Nationales de l'Infectiologie 2023   01 mai 2023
Performance of the cobas® HBV RNA automated investigational assay for the detection and quantification of circulating HBV RNA in chronic HBV patients.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology   04 avril 2022
Divergent patterns of hbv-rna and hbcrag levels in untreated chronic hepatitis delta: a large european cross-sectional study
Abstracts of the 54th A.I.S.F. - Italian Association for the Study of the Liver - Annual Meeting 2022   01 mars 2022
What is the impact of the decrease of hepatitis C virus incidence on the value of current prognostic models for hepatocellular carcinoma?
HPB : the official journal of the International Hepato Pancreato Biliary Association   01 janvier 2020
How to improve access to therapy in hepatitis B patients.
Liver international : official journal of the International Association for the Study of the Liver   12 août 2019
Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients.
Journal of hepatology   07 décembre 2018
Perspectives and limitations for nucleo(t)side analogs in future HBV therapies.
Current opinion in virology   16 mai 2018
Interaction between Toll-Like Receptor 9-CpG Oligodeoxynucleotides and Hepatitis B Virus Virions Leads to Entry Inhibition in Hepatocytes and Reduction of Alpha Interferon Production by Plasmacytoid Dendritic Cells.
Antimicrobial agents and chemotherapy   27 mars 2018
How to improve access to therapy in hepatitis B patients
Proceedings of the 11th Paris Hepatology Conference. International Conference on the Management of Liver Diseases   10 février 2018